Prostate Cancer - Results from #1600

Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. December 27, 2023

Value-based payment models and management of newly diagnosed prostate cancer. December 27, 2023

Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs. December 27, 2023

The Impact of Nutrient Supply on Prostate Cancer Risk Worldwide. December 27, 2023

Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy. December 27, 2023

Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management. December 26, 2023

What are the Most Important Objectives of Patients Undergoing Radical Prostatectomy? A Narrative Review. December 26, 2023

Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. December 26, 2023

A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male - A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer. December 26, 2023

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer. December 26, 2023

Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer. December 26, 2023

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. December 26, 2023

Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer. December 26, 2023

First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer. December 25, 2023

Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer. December 25, 2023

Blood-based liquid biopsy in advanced prostate cancer. December 25, 2023

Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study. December 25, 2023

Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment. December 25, 2023

First patient dosed in Clarity’s registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA December 22, 2023

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits. December 22, 2023

Page 81 of 1436